Connecting Science, Innovation, and Collaboration at BIO Asia–Taiwan

This July, Healthcare-Plus had the opportunity to participate in one of Taiwan's 

leading biotechnology exhibitions, where professionals across the medical, food, 

healthcare, and life science industries gathered to exchange ideas and explore 

future opportunities.

The exhibition reinforced an important message:

The future of biotechnology is not simply about selling products—it is about delivering 

science-based solutions.

One of the most dynamic areas continues to be the pet healthcare market.

While many pet health products have traditionally been adapted from human applications, 

today's market is demanding much more:


• Scientifically validated ingredients and formulations


• Evidence-based efficacy that builds trust


• Solutions designed specifically for different species and medical needs

With Taiwan's veterinary healthcare ecosystem continuing to evolve, significant opportunities 

remain for innovation and collaboration.

Beyond pet healthcare, the exhibition also highlighted another key trend:

Innovation happens when the entire value chain works together.

From raw material suppliers and R&D partners to manufacturers and brand owners, every 

stage plays a critical role in bringing meaningful healthcare solutions to market.

At Healthcare-Plus, we strive to be more than an ingredient supplier.

We aim to serve as a bridge—connecting global technologies, scientific expertise, and industry 

partners to accelerate innovation and create long-term value.

This year's exhibition reaffirmed three key drivers shaping the future of biotechnology:

• Science builds trust.


• Collaboration creates value.


• Innovation drives the future.

No company advances the industry alone.

By sharing knowledge, building partnerships, and connecting expertise, we can unlock greater 

possibilities for Taiwan's biotechnology ecosystem.